Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Chris Lange | Oct 28, 2017 at 10:05 AM EDT

Top Biopharma Events Coming by the End of 2017

24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Jon C. Ogg | Oct 18, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs,…

Jon C. Ogg | Oct 16, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

The top analyst upgrades, downgrades and other research calls from Monday include Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 7, 2017 at 12:10 PM EDT

How Bristol-Myers Actually Won by Stopping a Clinical Study

Usually when a clinical study is stopped it spells disaster for the company performing the study, but in this case…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 17 18 19 20 21 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

How Bristol-Myers Actually Won by Stopping a Clinical Study

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major Pharma Short Sellers Become More Selective

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Top Analyst Upgrades and Downgrades: Adobe, Apple, Bristol-Myers, Citigroup, Ford, Groupon, Phillips 66, United Rentals and More

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

How Bristol-Myers Actually Won by Stopping a Clinical Study

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major Pharma Short Sellers Become More Selective

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It